Allergan

Photos »

  /  
News across the web »
Interact & exchange stock tips & market info »
Related News »
A lawsuit seeking $60.5 million that blamed Irvine-based Allergan for causing a man’s devastating disease has been settled. Thomas McGee of Missouri got Botox injections for back pain and later was diagnosed with Guillain-Barre Syndrome. 
May 24, 2012 at 07:51 | Source: Orange County Register
Irvine-based Allergan Inc., which makes Botox and the Lap-Band, has signed a lease on a 93,000-square-foot research and development facility in Bridgewater, N.J. The facility is expected to create several hundred new jobs over the next three to ...
May 17, 2012 at 18:43 | Source: msnbc.com
Law360, New York (May 25, 2012, 8:18 PM ET) -- Allergan Inc. and two Japanese drug makers urged a Delaware federal court Thursday to pause Apotex Inc.'s monopolization suit over Allergan's decision to market a new formulation of Zymar until an underlying ...
May 26, 2012 at 00:17 | Source: site.law360.com
Monday, May 21, 2012... Allergan (NYSE:AGN) closed Friday's unfavorable trading session at $88.78. In the past year, the stock has hit a 52-week low of $69.40 and 52-week..... Tuesday, May 15, 2012... Allergan (NYSE:AGN) closed Monday's negative trading ...
May 25, 2012 at 11:53 | Source: Market Intelligence Center
Allergan ( AGN) recently announced that Botox (botulinum toxin type A) has been recommended by the National Institute for Health and Clinical Excellence (NICE) in the final draft guidance. NICE is recommending the use of the product for the ...
May 16, 2012 at 23:02 | Source: NASDAQ
New York, May 21st (TradersHuddle.com) - Shares of Allergan Inc. (NYSE:AGN) closed the trading session at $88.78 below calculated support at $90.66. The stock broke down technically, raising concerns as the move might trigger additional selling. Allergan ...
May 21, 2012 at 11:22 | Source: TradersHuddle.com
17 days ago, on May 2nd, 2012, Allergan (AMEX:AGN) reported its earnings. Analysts, on average, expected earnings of $0.87 per share on sales of $1.4 billion. Allergan actually reported earnings of $0.86 per share on sales of $1.4 billion, missing EPS ...
May 19, 2012 at 12:57 | Source: Financial News Network Online
Allergan (AGN) recently announced that Botox (botulinum toxin type A) has been recommended by the National Institute for Health and Clinical Excellence (NICE) in the final draft guidance. NICE is recommending the use of the product for the ...
May 16, 2012 at 22:26 | Source: Yahoo Finance
OpenText, the leading provider of business process management (BPM), dynamic case management and enterprise architecture (EA) software and solutions, today announced that its customer Allergan, a multi-specialty healthcare company, will present its ...
May 23, 2012 at 18:22 | Source: PRWeb
When Allergan (AMEX:AGN) reported earnings 12 days ago on May 2nd, 2012, analysts, on average, expected the company to report earnings of $0.87 on sales of $1.4 billion. The company actually reported EPS of $0.86 on sales of $1.4 billion, missing EPS ...
May 14, 2012 at 15:12 | Source: Comtex Smartrend